TCW Group’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

TCW Group’s Portfolio AUXL Stock Details AUXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-24,823	Closed	-$413K	–	755
2013 Q2	$413K	Buy	+24,823	New	+$396K	﹤0.01%	695

Other funds holding AUXL

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

TCW Group's AUXL Position: Q3 2013 in Review

TCW Group sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q3 2013, closing a stake of 24,823 shares — an estimated $413K sold.

TCW Group first reported a position in AUXL in Q2 2013 and held it in 1 quarter. The position peaked at $413K in Q2 2013. 150 funds tracked by Wall St. Rank hold AUXL as of Q3 2013.

TCW Group reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q3 2013 after selling out during the quarter.
TCW Group sold 24,823 AUXILIUM PHARAMCEUTICALS INC shares in Q3 2013, an estimated $413K.
TCW Group first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q2 2013 and held it in 1 quarter.
TCW Group's AUXILIUM PHARAMCEUTICALS INC position peaked at $413K in Q2 2013.
150 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q3 2013.

Based on TCW Group's 13F filing for Q3 2013, filed 14 Nov 2013.